CPSA Shanghai 2017

Clinical and Pharmaceutical Success from Discovery to Regulatory Approval: Biomarkers, Modeling, and Analytical Technologies

Innovator Awards     |    Past Recipients

Abstracts submission is closed for the CPSA Shanghai 2017 Innovator Award.

Deadline for submission is: March 31, 2017

The CPSA Shanghai Innovator Award provides formal recognition for innovative technologies, products and services presented at the annual meeting.

If your submission is for the Young Scientist Excellence Award, please submit your abstract through the Young Scientist Abstract Submission Page.

  • The Innovator Award is open to all participants in the CPSA Shanghai Exhibition (CPSA EXPO)
  • Applicants can supply for consideration either an abstract for poster session or a standalone abstract without participating in the poster session
  • Applications will be formally reviewed by the Innovator Award Committee
  • Participants will be assigned to present in the Poster Session and/or the Innovator Award Symposium Session
  • There is no limit to the number of submissions per exhibitor, however, each application must describe a unique technology, product and/or service as determined by the Innovator Award Committee
  • Recipient(s) of the CPSA Shanghai Innovator Award will be formally recognized in the Closing Ceremony on Friday, April 22.

Innovator Award Committee

Robert Dodge, Bristol-Myers Squibb
Yi Du, HuaHai Pharmaceutical Co., Ltd.
Xianyu Jiang, WuXi
Wenzhe Lu, Roche
Yi-Min She, Shanghai Center for Plant Stress Biology

2016 Innovator Award Recipients

Tim Schlabach   Novilytic
Advances in Blood Collection and Plasma Preparation for Clinical Trials

Haiwei Xiong   WuXi AppTec
Development of the in vitro fluorescence-based human OATP1B1 and OATP1B3 Model for DDI evaluation